title: Intravenous infusion of 4-AP in chronic spinal cord injured subjects.
abstract: METHODS
  A prospective double blind cross over trial of intravenous 4-Aminopyridine (4-AP).
  
  
  OBJECTIVE
  To determine the efficacy of this drug in the treatment of spinal cord injured (SCI) patients for neurologic impairment, pain and spasticity.
  
  
  METHODS
  The post anesthesia care unit (PACU) of a tertiary care acute hospital.
  
  
  METHODS
  Twelve paraplegic patients were enrolled in a double blind cross over intravenous trial of 4-Aminopyridine (4-AP). Thirty milligrams of 4-AP or placebo were administered over a 2 h period. Patients were serially examined during and after the infusion clinically for pain, sensorimotor function, hypertonicity and motor control using electromyography (EMG). Samples of blood and cerebrospinal fluid (CSF) were also analyzed at similar intervals.
  
  
  RESULTS
  Despite penetration of 4-AP into the CSF, no significant differences were noted in the clinical and EMG parameters at the times measured. Individual changes in sensory function were reported by some patients in both the placebo and 4-AP trials, however mean values were not robust. Frequently, patients complained of unpleasant symptoms during the 4-AP infusion.
  
  
  CONCLUSIONS
  The intravenous route may not be the best way to administer this drug as no short term benefits were observed.
authors.affiliation: The University of Texas Houston Medical School, USA.
authors.forename: W H
authors.initials: WH
authors.lastname: Donovan
authors.forename: J A
authors.initials: JA
authors.lastname: Halter
authors.forename: D E
authors.initials: DE
authors.lastname: Graves
authors.forename: A R
authors.initials: AR
authors.lastname: Blight
authors.forename: O
authors.initials: O
authors.lastname: Calvillo
authors.forename: M T
authors.initials: MT
authors.lastname: McCann
authors.forename: A M
authors.initials: AM
authors.lastname: Sherwood
authors.forename: T
authors.initials: T
authors.lastname: Castillo
authors.forename: K C
authors.initials: KC
authors.lastname: Parsons
authors.forename: J R
authors.initials: JR
authors.lastname: Strayer
mesh_terms: D015761:4-Aminopyridine / Q000008:administration & dosage* / Q000009:adverse effects / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004576:Electromyography; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009068:Movement; D009132:Muscles / Q000503:physiopathology; D009420:Nervous System / Q000503:physiopathology; D010146:Pain / Q000503:physiopathology; D011446:Prospective Studies; D012677:Sensation; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D015761:4-Aminopyridine